UTMB scientists awarded $11.3 million for new studies on Ebola virus

GALVESTON, TEXAS – Researchers at the University of Texas Medical Branch at Galveston have been awarded an $11.3 Million, multi-year grant from the National Institute of Allergy and Infectious Diseases to study immunopathogenesis of Ebola, and in particular to determine why cells infected with Ebola develop “immune system paralysis,” which inhibits immune response, leads to…

Details

New innovation successfully treats neonatal hypothermia

Neonatal hypothermia — which occurs when an infant’s core body temperature falls below the normal range needed to maintain health — contributes to approximately one million deaths each year, and countless cases of stunted growth, almost exclusively in low- and middle-income countries. To address this common but preventable condition, researchers from Boston Children’s Hospital, engineers…

Details

Latest peer-reviewed research: Immediate global ivermectin use will end COVID-19 pandemic

WASHINGTON, D.C. – Peer reviewed by medical experts that included three U.S. government senior scientists and published in the American Journal of Therapeutics, the research is the most comprehensive review of the available data taken from clinical, in vitro, animal, and real-world studies. Led by the Front Line COVID-19 Critical Care Alliance (FLCCC), a group…

Details